CHRISTOPHER KRIPPINGER: Open Payments
NPI 1801301494 · EVERGREEN PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,003 in 129 payments from 18 companies in 2025. Trend: 2023 $2,422 · 2024 $1,934 · 2025 $3,003
Food & beverage: $2,775Education: $228
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $419 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $377 |
| Novartis Pharmaceuticals Corporation | 13 | $324 |
| GENZYME CORPORATION | 6 | $270 |
| UCB, Inc. | 10 | $254 |
| Lilly USA, LLC | 14 | $247 |
| Incyte Corporation | 11 | $239 |
| Janssen Biotech, Inc. | 6 | $183 |
| Amgen Inc. | 6 | $158 |
| Organon LLC | 8 | $126 |
Products named: DUPIXENT, Bimzelx, OPZELURA, SKYRIZI, RINVOQ, TREMFYA, COSENTYX, EBGLYSS.
Industry payments across IL — which companies pay providers there.
